{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:53:24Z","timestamp":1793300004473,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Vitamin K supplementation can reduce progression of vascular calcification in patients with diabetes or end-stage kidney disease. Presently, it is unknown whether vitamin K is also beneficial in patients with symptomatic atherosclerotic coronary artery disease (CAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether supplementation with the vitamin K homologue menaquinone-7 (MK-7) for a period of 2 years attenuates the progression of coronary artery calcification (CAC) compared with placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This randomized placebo-controlled clinical trial including symptomatic patients with CAC score between 50 and 400 Agatston units (AU) with 2 years of follow-up (VitaK-CAC study). The study was conducted at 1 university hospital and 1 community-dwelling hospital in the Netherlands. Data were collected from January 2012 through October 2022 with a few interruptions; analyses were performed from January 2023 to April 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Supplementation with either the vitamin K homologue menaquinone-7 (MK-7) in a daily dose of 360 \u00b5g or identical placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome of the study was the evolution of the CAC score and calcium mass at 1 and 2 years of follow-up, as measured with computed tomography (CT) scanning. Additionally, CT angiography was performed. The incidence of new calcifications was a secondary outcome measure. Data were analyzed using a generalized estimation equations model, adjusted for covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Altogether, 180 patients could be randomized (90 patients per group), with 85 patients receiving MK-7 (median [IQR] age, 59 [54-65] years; 36 [42%] female) and 82 receiving placebo (median [IQR] age, 61 [54-65] years; 34 [42%] female). Baseline characteristics were comparable for the 2 groups. Plasma levels of MK-7 rose significantly in the active treatment group (median [IQR], 0.50 [0.32-0.77] \u00b5g\/L to 6.56 [2.04-10.35] \u00b5g\/L;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). In the placebo group, CAC scores increased from a median (IQR) of 145 (99-217) AU to 173 (119-297) AU after the first year and to 214 (148-344) AU after the second. In the active treatment group, these values were 135 (89-226), 150 (110-254) and 184 (122-298) AU, respectively. The difference between the groups was significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02), even after adjustment for covariates. A similar result was seen for calcium mass. The increase in CAC score correlated with the number of noncalcified plaques that became partially calcified during the study (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.17;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04). No significant adverse effects were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The findings of this study suggest that supplementation with MK-7 for 2 years may slow calcification in noncalcified plaques of patients with symptomatic CAD. The clinical significance of this finding in terms of plaque stability remains to be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01002157\">NCT01002157<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2026.1279","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:24Z","timestamp":1781105424000},"page":"719","source":"Crossref","is-referenced-by-count":10,"title":["Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification"],"prefix":"10.1001","volume":"11","author":[{"given":"Liv M.","family":"Vossen","sequence":"first","affiliation":[{"name":"Department of Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"de Leeuw","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Schurgers","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands"},{"name":"Department of Biochemistry, University of Maastricht, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Heuts","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouke P.","family":"Adriaans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, VieCuri MC, Venlo, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"de Haan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"van Varik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wilhelmina Ziekenhuis Assen, Assen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham A.","family":"Kroon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"hoi260027r1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/heartjnl-2018-313955","article-title":"Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis.","volume":"105","author":"Lees","year":"2019","journal-title":"Heart"},{"issue":"10","key":"hoi260027r2","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.3390\/nu12102909","article-title":"Vitamin K supplementation for the prevention of cardiovascular disease: where is the evidence? a systematic review of controlled trials.","volume":"12","author":"Vlasschaert","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"hoi260027r3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.20452\/pamw.3041","article-title":"Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5.","volume":"125","author":"Kurnatowska","year":"2015","journal-title":"Pol Arch Med Wewn"},{"issue":"1","key":"hoi260027r4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1681\/ASN.2019060579","article-title":"Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie Study.","volume":"31","author":"De Vriese","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"hoi260027r5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/ajcn\/nqab306","article-title":"The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.","volume":"115","author":"Bellinge","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"hoi260027r6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/ckj\/sfac184","article-title":"Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial.","volume":"15","author":"Saritas","year":"2022","journal-title":"Clin Kidney J"},{"issue":"6","key":"hoi260027r7","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3945\/ajcn.2008.27338","article-title":"Vitamin K supplementation and progression of coronary artery calcium in older men and women.","volume":"89","author":"Shea","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"hoi260027r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100643","article-title":"Effects of vitamin K2 and D supplementation on coronary artery disease in men: a RCT.","volume":"2","author":"Hasific","year":"2023","journal-title":"JACC Adv"},{"issue":"8","key":"hoi260027r9","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1182\/blood-2006-08-040709","article-title":"Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.","volume":"109","author":"Schurgers","year":"2007","journal-title":"Blood"},{"issue":"11","key":"hoi260027r10","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.3390\/nu7115443","article-title":"Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: rationale and study protocol (VitaK-CAC Trial).","volume":"7","author":"Vossen","year":"2015","journal-title":"Nutrients"},{"issue":"2","key":"hoi260027r11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.atherosclerosis.2012.09.019","article-title":"The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.","volume":"225","author":"Dalmeijer","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"hoi260027r12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.","volume":"59","author":"Westenfeld","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"hoi260027r13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clinbiochem.2020.05.005","article-title":"Uncarboxylated matrix Gla-protein: a biomarker of vitamin K status and cardiovascular risk.","volume":"83","author":"Jespersen","year":"2020","journal-title":"Clin Biochem"},{"issue":"8","key":"hoi260027r14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcmg.2017.05.007","article-title":"Coronary artery calcium scoring: is it time for a change in methodology?","volume":"10","author":"Blaha","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"hoi260027r15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiol.2432050808","article-title":"Coronary artery calcium: a multi-institutional, multimanufacturer international standard for quantification at cardiac CT.","volume":"243","author":"McCollough","year":"2007","journal-title":"Radiology"},{"issue":"3","key":"hoi260027r16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1590\/0100-3984.2015.0235","article-title":"Coronary artery calcium score: current status.","volume":"50","author":"Neves","year":"2017","journal-title":"Radiol Bras"},{"issue":"22","key":"hoi260027r17","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.jacc.2013.02.065","article-title":"Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome.","volume":"61","author":"Versteylen","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi260027r18","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.jcmg.2022.07.002","article-title":"CAD-RADS\u2122 2.0\u20142022 Coronary Artery Disease\u2013Reporting and Data System: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI).","volume":"15","author":"Cury","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"hoi260027r19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2369-15-145","article-title":"Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.","volume":"15","author":"Delanaye","year":"2014","journal-title":"BMC Nephrol"},{"issue":"12","key":"hoi260027r20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jcmg.2010.08.018","article-title":"Progression of coronary artery calcium predicts all-cause mortality.","volume":"3","author":"Budoff","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"hoi260027r21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.ajkd.2024.06.018","article-title":"Progression of coronary artery calcification and risk of clinical events in CKD: the Chronic Renal Insufficiency Cohort Study.","volume":"85","author":"Tian","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"hoi260027r22","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/01.ATV.0000127024.40516.ef","article-title":"Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy.","volume":"24","author":"Raggi","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"hoi260027r23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2214\/ajr.182.5.1821327","article-title":"Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability.","volume":"182","author":"Hokanson","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"hoi260027r24","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2025.1001321","article-title":"Adherence to dietary supplementation with menaquinone-7, a vitamin K2 analogue.","author":"Vossen","year":"2025","journal-title":"Explor Med"},{"issue":"10","key":"hoi260027r25","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.ekir.2024.07.033","article-title":"Statin use and the progression of coronary artery calcification in CKD: findings from the KNOW-CKD study.","volume":"9","author":"Yang","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"11","key":"hoi260027r26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11883-023-01151-w","article-title":"Statin use and coronary artery calcification: a systematic review and meta-analysis of observational studies and randomized controlled trials.","volume":"25","author":"Shahraki","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"hoi260027r27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcmg.2015.02.006","article-title":"Coronary artery calcium scanning: past, present, and future.","volume":"8","author":"Hecht","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"hoi260027r28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk.","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi260027r29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12944-024-02255-1","article-title":"Coronary artery calcification burden, atherogenic index of plasma, and risk of adverse cardiovascular events in the general population: evidence from a mediation analysis.","volume":"23","author":"Yao","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"2","key":"hoi260027r30","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13892","article-title":"Coronary artery calcium score and its association with stroke: a systematic review and meta-analysis.","volume":"53","author":"Kwok","year":"2023","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"hoi260027r31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejrad.2005.12.027","article-title":"Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort\u2013consequences for progression studies.","volume":"57","author":"Hoffmann","year":"2006","journal-title":"Eur J Radiol"},{"issue":"2","key":"hoi260027r32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/HYPERTENSIONAHA.114.04494","article-title":"Inactive matrix Gla protein is causally related to adverse health outcomes: a mendelian randomization study in a Flemish population.","volume":"65","author":"Liu","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"hoi260027r33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036459","article-title":"Inactive matrix Gla protein and cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis.","volume":"14","author":"Berlot","year":"2025","journal-title":"J Am Heart Assoc"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2850256\/jamacardiology_vossen_2026_oi_260027_1786123780.09824.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:00:41Z","timestamp":1786546841000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2850256"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2026.1279","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}